MediciNova (MNOV): Advancing Breakthrough Therapies for ALS, NASH, and Fibrotic Diseases
MediciNova Inc. (MNOV) is an innovative biopharmaceutical company with a late-stage clinical pipeline targeting diseases with significant unmet…
Browsing Tag